ConductScience.org, home

Paper5337697

Introduction to the biochemistry of D-arabinosyl nucleosides.

Cohen SS. Prog Nucleic Acid Res Mol Biol, 1966. Cited by 124 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Introduction to the biochemistry of D-arabinosyl nucleosides. Papers, record 5337697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5337697

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Introduction to the biochemistry of D-arabinosyl nucleosides.
PubMed
Journal
Prog Nucleic Acid Res Mol Biol
PubMed
Year
1966
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
124
iCite
Revised in PubMed
2019-10-30
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cohen SSS S

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NucleosidesMajor topic
Arabinose
Chemistry, Organic
Culture Techniques
Escherichia coli
Nucleotides
Nucleotidyltransferases
Organic Chemistry Phenomena

Source PubMed

Download CSV of topics

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 124 citations.

PMIDTitleJournalYearIn PapersSource
38535455Marine-Derived Anticancer Agents Targeting Apoptotic Pathways: Exploring the Depths for Novel Cancer Therapies.Mar Drugs2024https://conductscience.org/library/papers/38535455PubMed
37243232Hydrogen Bonding (Base Pairing) in Antiviral Activity.Viruses2023https://conductscience.org/library/papers/37243232PubMed
31633499An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia.Anticancer Drugs2020https://conductscience.org/library/papers/31633499PubMed
27281742Approved Antiviral Drugs over the Past 50 Years.Clin Microbiol Rev2016https://conductscience.org/library/papers/27281742PubMed
22920396The clinically relevant pharmacogenomic changes in acute myelogenous leukemia.Pharmacogenomics2012https://conductscience.org/library/papers/22920396PubMed
15825318Effect of adenosine deaminase upon the antiviral activity in vitro of adenine arabinoside for vaccinia virus.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15825318PubMed
7525187Evolution of the arabinosides and the pharmacology of fludarabine.Drugs1994https://conductscience.org/library/papers/7525187PubMed
7062908Effect of arabinosyl cytosine on the level of DNA polymerase and thymidine kinase activity in PHA-stimulated human tonsillar lymphocytes.Mol Cell Biochem1982https://conductscience.org/library/papers/7062908PubMed
6998693Vidarabine: a preliminary review of its pharmacological properties and therapeutic use.Drugs1980https://conductscience.org/library/papers/6998693PubMed
6651280Comparison of the efficacy of vidarabine, its carbocyclic analog (cyclaradine), and cyclaradine-5'-methoxyacetate in the treatment of herpes simplex virus type 1 encephalitis in mice.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6651280PubMed
6255863Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6255863PubMed
6166246Inhibition of hepatitis B virus deoxyribonucleic acid polymerase by the 5'-triphosphates of 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6166246PubMed
5699806Repair replication and degradation of bromouracil-substituted DNA in mammalian cells after irradiation with ultraviolet light.Biophys J1968https://conductscience.org/library/papers/5699806PubMed
5695537Characterization of an inhibitor for Lactobacillus bulgaricus in tomato juice.Appl Microbiol1968https://conductscience.org/library/papers/5695537PubMed
5244747Behavioral and biochemical effects of intracranial injection of cytosine arabinoside in goldfish.Proc Natl Acad Sci U S A1968https://conductscience.org/library/papers/5244747PubMed
4981070Control of pigment production in mouse melanoma cells in vitro. Evocation and maintenance.J Cell Biol1969https://conductscience.org/library/papers/4981070PubMed
4919542Pyrimidine metabolism in microorganisms.Bacteriol Rev1970https://conductscience.org/library/papers/4919542PubMed
4840442Thermal inactivation as a means of inhibiting the serum-associated deamination of 9-beta-D Arabinofuranosyladenine in tissue culture media.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4840442PubMed
4790562Target-organ treatment of neurotropic virus diseases: efficacy as a chemotherapy tool and comparison of activity of adenine arabinoside, cytosine arabinoside, idoxuridine, and trifluorothymidine.Antimicrob Agents Chemother1972https://conductscience.org/library/papers/4790562PubMed
4595569DNA repair in Escherichia coli mutants deficient in DNA polymerases I, II and-or 3.Proc Natl Acad Sci U S A1974https://conductscience.org/library/papers/4595569PubMed

See all 37 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5337697

GET https://conductscience.org/api/papers/v1/5337697/cited_by?page=2